resveratrol + rosiglitazone

Resveratrol + rosiglitazone is a combination of two small molecules, resveratrol and rosiglitazone. Resveratrol is a natural polyphenolic compound found in grapes and other plants, known for its antioxidant properties and ability to activate SIRT1, PGC-1α, and JNK pathways. Rosiglitazone is a thiazolidinedione class antidiabetic agent that acts as an agonist of peroxisome proliferator-activated receptor gamma (PPAR-γ), improving insulin sensitivity in adipose tissue. The combination has been studied for synergistic effects on metabolic processes such as fatty acid re-esterification in adipose tissue from obese individuals, with evidence suggesting enhanced gene expression related to metabolism (PDK4 and PEPCK) compared to either agent alone[1]. Additionally, resveratrol may counteract some adverse effects of rosiglitazone on vascular mineralization by reducing oxidative stress and osteoblast-like differentiation in vascular smooth muscle cells[2].